carnitine has been researched along with xanthenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, RW; Kim, S; Milbrandt, J; Sasaki, Y; Strickland, A; Viader, A; Workman, CS; Yang, K | 1 |
| Abecia, L; Anguita, J; Fornari, T; García-Cañas, V; García-Risco, MR; Peña-Cearra, A; Rodríguez, H; Simó, C | 1 |
2 other study(ies) available for carnitine and xanthenes
| Article | Year |
|---|---|
Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy.
Topics: Aniline Compounds; Animals; Axons; Blotting, Western; Carnitine; Cells, Cultured; Fatty Acids; Fluorescent Dyes; Ganglia, Spinal; Lipid Metabolism; Mice; Mice, Knockout; Mice, Transgenic; Microarray Analysis; Mitochondrial Encephalomyopathies; Nerve Degeneration; Peripheral Nervous System Diseases; Protein Serine-Threonine Kinases; Schwann Cells; Xanthenes | 2013 |
Resazurin-based high-throughput screening method for the discovery of dietary phytochemicals to target microbial transformation of L-carnitine into trimethylamine, a gut metabolite associated with cardiovascular disease.
Topics: Cardiovascular Diseases; Carnitine; Gastrointestinal Microbiome; High-Throughput Screening Assays; Humans; Methylamines; Oxazines; Phytochemicals; Xanthenes | 2022 |